A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells
Open Access
- 25 June 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (8) , 102205
Abstract
No abstract availableKeywords
Funding Information
- University of North Florida
- College of Arts and Sciences, Boston University
This publication has 53 references indexed in Scilit:
- Histone arginine methylationFEBS Letters, 2010
- A combinatorial approach to characterize the substrate specificity of proteinargininemethyltransferase 1Molecular BioSystems, 2010
- A Chloroacetamidine‐Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and In Vitro and In Vivo EvaluationChemBioChem, 2010
- Investigation of the Substrate Specificity of Lacticin 481 Synthetase by Using Nonproteinogenic Amino AcidsChemBioChem, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- The PRMT1 gene expression pattern in colon cancerBritish Journal of Cancer, 2008
- Protein Arginine Methyltransferase 1: Positively Charged Residues in Substrate Peptides Distal to the Site of Methylation Are Important for Substrate Binding and CatalysisBiochemistry, 2007
- Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphomaThe EMBO Journal, 2007
- Identification of a Peptoid Inhibitor of the Proteasome 19S Regulatory ParticleJournal of the American Chemical Society, 2007
- Quantitative Evaluation of the Relative Cell Permeability of Peptoids and PeptidesJournal of the American Chemical Society, 2007